Literature DB >> 19869879

EXPERIMENTAL NEPHRITIS IN THE FROG : II. PERFUSION METHODS OF TESTING THE KIDNEY BY DISSOCIATION OF ITS FUNCTIONS.

J Oliver1, E Shevky.   

Abstract

1. A method of testing the frog's kidney by means of perfusion is described. 2. This is made possible by dissociating, as far as possible, from the total function of the organ the functions of its constituent parts. 3. The characteristics by which tubular, glomerular, and combined tubular-glomerular lesions may be recognized are described.

Entities:  

Year:  1931        PMID： 19869879      PMCID： PMC2132027          DOI： 10.1084/jem.53.6.763

Source DB:  PubMed          Journal:  J Exp Med        ISSN： 0022-1007            Impact factor:   14.307


  3 in total

1.  A COMPARISON OF THE MANNER OF EXCRETION OF NEUTRAL RED AND PHENOL RED BY THE FROG'S KIDNEY.

Authors:  J Oliver; E Shevky
Journal:  J Exp Med       Date:  1929-06-30       Impact factor: 14.307

2.  EXPERIMENTAL NEPHRITIS IN THE FROG : I. THE ANATOMICAL EVIDENCE OF DAMAGE.

Authors:  J Oliver; P Smith
Journal:  J Exp Med       Date:  1930-07-31       Impact factor: 14.307

3.  A COMPARISON OF THE METHOD OF EXCRETION OF NEUTRAL RED AND PHENOL RED BY THE MAMMALIAN KIDNEY.

Authors:  E Mackay; J Oliver
Journal:  J Exp Med       Date:  1930-01-01       Impact factor: 14.307
  3 in total
  3 in total

1.  CELLULAR MECHANISMS OF RENAL SECRETION. A STUDY BY THE EXTRAVITAL METHOD : II. THE FUNCTIONAL PHASE OF THE SECRETORY MECHANISM.

Authors:  J R Oliver; E M Lund
Journal:  J Exp Med       Date:  1933-02-28       Impact factor: 14.307

2.  EXPERIMENTAL NEPHRITIS IN THE FROG : IV. THE SIGNIFICANCE OF THE FUNCTIONAL RESPONSE TO VASCULAR AND TO PARENCHYMAL DISTURBANCES IN THE KIDNEY.

Authors:  J Oliver
Journal:  J Exp Med       Date:  1932-01-31       Impact factor: 14.307

3.  EXPERIMENTAL NEPHRITIS IN THE FROG : III. THE EXTRAVITAL PRODUCTION OF ANATOMICAL LESIONS IN THE KIDNEY AND THEIR CORRELATION WITH THE FUNCTIONAL ASPECTS OF DAMAGE.

Authors:  J Oliver; P Smith
Journal:  J Exp Med       Date:  1931-05-31       Impact factor: 14.307
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.